ADAP Crisis Task Force Announces Continued Partnership with Bristol-Myers Squibb and Boehringer Ingelheim for AIDS Drug Assistance Programs in the United States

FOR IMMEDIATE RELEASE
Contact: Murray Penner
202-434-8090
mpenner@NASTAD.org

ADAP AlertOctober 28, 2013, Washington, DC – The ADAP Crisis Task Force (Task Force) announced today that it has reached agreement with Bristol-Myers Squibb (BMS) and Boehringer Ingelheim (BI) to extend voluntary discounts/rebates and price freezes to all state AIDS Drug Assistance Programs (ADAPs).  The continuation of existing agreements beyond 2013 will provide stability to ADAPs as they continue to navigate the uncharted terrain of a reformed health system as a result of implementation of the Affordable Care Act (ACA) and continued fiscal challenges at both the state and federal level.

The Task Force, convened by the National Alliance of State and Territorial AIDS Directors (NASTAD), previously secured continuation through 2014 of existing agreements for voluntary discounts and rebates from AbbVie, Gilead Sciences, Janssen Therapeutics, Merck and ViiV Healthcare.  Many of these agreements also provide continued price freezes for ADAPs for varying lengths of time into 2014 and 2015.  Continue reading

ADAP Crisis Task Force Announces Agreement with ViiV Healthcare for Tivicay®

FOR IMMEDIATE RELEASE
Contact: Meico Whitlock
202-434-8090

ADAP Crisis Task Force Announces Agreement with ViiV Healthcare for TivicayAugust 26, 2013, Washington, DC – The ADAP Crisis Task Force (ACTF) has reached a new pricing agreement with ViiV Healthcare for AIDS Drug Assistance Programs (ADAPs) for Tivicay® (dolutegravir) for the treatment of HIV-1 infected individuals. The agreed-upon ADAP direct purchase price for Tivicay®, negotiated between the ACTF and ViiV, is substantially lower than the wholesale acquisition cost (WAC), reflecting voluntary discounts that are also significantly below the mandated 340B pricing of the medication.

Continue reading

ADAP Crisis Task Force Announces Agreement with Industry Partners

FOR IMMEDIATE RELEASE
Contact: Murray Penner
202-434-8090
mpenner@NASTAD.org

ADAP Crisis Task ForceJuly 29, 2013, Washington, DC – As part of ongoing efforts by the ADAP Crisis Task Force (Task Force) and the pharmaceutical industry to address the continued need for access to HIV antiretroviral medicines through AIDS Drug Assistance Programs (ADAPs), the Task Force announced today that it has reached agreement with AbbVie, Gilead Sciences, Merck, and ViiV Healthcare to extend the voluntary discounts/rebates and price freezes available to all state ADAPs through December 31, 2014.

Continue reading

Action Alert: Urge Congress to Fully Fund Domestic HIV/AIDS and Viral Hepatitis Programs

By Emily McCloskey, Manager, Policy and Legislative Affairs, NASTAD

Action: Contact your Senators to ask them to fully fund domestic HIV/AIDS and viral hepatitis programs

NHTD 2013 Call In DayThe Senate Appropriations Committee is expected to vote on the bill that funds domestic HIV/AIDS and viral hepatitis programs the week of July 7. The National Alliance of State and Territorial AIDS Directors (NASTAD) and the larger HIV community are leading a call in day on June 27 to ask the Senate to help prevent further cuts and to fully fund domestic HIV/AIDS and viral hepatitis prevention, care, treatment, and research programs. Calls on this issue to individual offices can make a difference. Please send the action alert to your networks and communities. If possible, NASTAD also asks you to reach out to your Senators on June 27, National HIV Testing Day (NTHD), and let them know the importance of HIV and viral hepatitis programs. Continue reading

What It Means To Be an AIDS Drug Assistance Program (ADAP) Coordinator

By Chis Hanson, AIDS Drug Assistance Program (ADAP) Coordinator, Michigan Department of Community Health

Background

Chris Hanson, ADAP Coordinator, Michigan Department of Community Health

Chris Hanson, ADAP Coordinator, Michigan Department of Community Health

In collaboration with the Health Resources and Services Administration (HRSA) and as a component of our HRSA Cooperative Agreement, NASTAD is releasing a set of videos related to AIDS Drug Assistance Program (ADAP) efficiency and program management. These videos are a companion to the ADAP Technical Assistance (TA) brief series released in winter 2012. Throughout the course of the past year, NASTAD compiled lessons learned from ADAP coordinators on a variety of topics including the use of data, implementation of cost-containment measures, challenges and successes in managing an ADAP, and advice for working within the program. The videos being released today address challenges and successes in management and ADAP and include advice from seasoned ADAP coordinators for working within the program.  Continue reading